Funded Tech Companies

Nkarta

Nkarta is a biopharmaceutical company, based in San Francisco. Financial backing was provided by SR One Capital Management, Amgen Ventures and Deerfield Capital.

Company Overview

Contact Information

Company Background Information

Overview

Nkarta (Nasdaq: NKTX) seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies. While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited to a few hematologic malignancies and the side effects can be severe.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/10/2020

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Paul Hastings

        

Chief Financial Officer

Matthew Plunkett

        

Chief Medical Officer

Kanya Rajangam

        

Chief Scientific Officer

James Trager

        

VP - Bus. Development

Nadir Mahmood

        

VP - Manufacturing

Ralph Brandenberger

        

Company Investors

• SR One Capital Management
• Amgen Ventures
• Deerfield Capital
• Novo Ventures
• New Enterprise Associates
• Life Sciences Partners
• Logos Capital
• Samsara BioCapital (Michael Dybbs)
• RA Capital

Browse more funded tech companies:

NK IO | NKN

Share this article

About Our Venture Capital Transactions Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary